Introduction
============

As the leading cause of death in Korea \[[@b1-crt-2016-092]\], cancer has been the country's main public health concern since 1983. Over 224,000 patients were newly diagnosed with cancer in Korea, and one in four deaths is due to cancer \[[@b2-crt-2016-092]\]. Although the cancer registration system in Korea is highly efficient and it can provide nationwide cancer statistics within a relatively brief period, a lag time of at least 2 years is required to collect, compile, and analyze the data of a specific year. For planning and implementation of comprehensive cancer control programs, it is important to assess the number of new cases and deaths that are expected to occur during the current year. In this study, we report the projected cancer incidence and mortality for the year 2016 based on data from the 1990s through 2014.

Materials and Methods
=====================

The Korean Ministry of Health and Welfare initiated a nationwide, hospital-based cancer registry, the Korea Central Cancer Registry (KCCR), in 1980. The history, objectives, and activities of the KCCR have been documented in detail elsewhere \[[@b3-crt-2016-092]\]. Incidence data from 1999 to 2013 were obtained from the Korea National Cancer Incidence Database. Cancer cases were classified according to the International Classification of Diseases for Oncology, 3rd edition \[[@b4-crt-2016-092]\], and converted according to the International Classification of Diseases, 10th edition (ICD-10) \[[@b5-crt-2016-092]\]. Mortality data from 1993 to 2014 were acquired from Statistics Korea \[[@b1-crt-2016-092]\]. The cause of death was coded and classified according to ICD-10 \[[@b5-crt-2016-092]\].

The cancer sites included in this study were (1) all cancers combined and (2) the 24 common cancers as follows: lip, oral cavity, and pharynx (C00-C14), esophagus (C15), stomach (C16), colon and rectum (C18-C20), liver and intrahepatic bile duct (liver) (C22), gallbladder and other parts of the biliary tract (gallbladder) (C23-C24), pancreas (C25), larynx (C32), lung and bronchus (lung) (C33-C34), breast (C50), cervix uteri (C53), corpus uteri (C54), ovary (C56), prostate (C61), testis (C62), kidney (C64), bladder (C67), brain and central nervous system (C70-C72), thyroid (C73), Hodgkin lymphoma (C81), non-Hodgkin lymphoma (C82-C85, C96), multiple myeloma (C90), leukemia (C91-C95), and others.

Population data from 1993 to 2015 were obtained from the resident registration population, reported by Statistics Korea. Data on the mid-year population, as of July 1 of the respective year, were analyzed. For the year 2016, however, we used population data as of December 31, 2015, because mid-2015 resident registration population data were not yet available at the time of analysis.

Due to the time required for data collection, compilation, quality control, and analysis, incidence and mortality data for a specific year are usually available 2-3 years later. Therefore, to provide an estimate of the nation's current cancer burden, we attempted to project, the expected number of new cancer cases and deaths in Korea for 2016. Linear regression models \[[@b6-crt-2016-092]\] were used to assess the time trends and projections. A simple linear or log-linear model of age-specific rates provide a good fit to the data, and it gives accurate predictions over a short time span \[[@b7-crt-2016-092]\]. Based on observed cancer incidence data from 1999 to 2013, a linear regression model was fitted to the age-specific rates by 5-year age groups against the observed years.

To predict the cancer incidence and mortality in 2016, we first performed a *Joinpoint* regression analysis on the data available to detect the year when significant changes occurred in cancer trends according to sex and cancer site. A *Joinpoint* regression describes changes in data trends by connecting several different line segments on a log scale at "joinpoints." This analysis was performed using the *Joinpoint* software (ver. 4.0.1, <http://surveillance.cancer.gov/joinpoint>) from the Surveillance Research Program of the US National Cancer Institute \[[@b8-crt-2016-092]\]. We chose the number of joinpoints to ensure that there would be at least five data points between consecutive joinpoints. However, for thyroid cancer, which has recently shown significant decreasing trends, we selected three joinpoints, although the last segment had only three data points.

We summarized the results by using crude rates (CRs) and age-standardized rates (ASRs) of cancer incidence and mortality. ASRs were standardized using the world standard population \[[@b9-crt-2016-092]\] and expressed as rates per 100,000 persons.

Results
=======

1. Incidence
------------

A total of 254,962 new cancer cases are anticipated in 2016 ([Table 1](#t1-crt-2016-092){ref-type="table"}, [Fig. 1](#f1-crt-2016-092){ref-type="fig"}), with more male (n=131,224) than female (n=123,738) cancer patients expected in the coming year.

The projected CRs per 100,000 of all sites combined in 2016 are projected to be 511.2 and 482.3 in men and women, respectively. The projected ASRs per 100,000 of all sites combined are 340.0 and 298.8, respectively ([Table 2](#t2-crt-2016-092){ref-type="table"}). In men, the five leading primary sites of cancer are expected to be the colon and rectum (CR, 91.2; ASR, 59.6), stomach (CR, 91.0; ASR, 59.0), lung (CR, 65.9; ASR, 42.3), liver (CR, 45.0; ASR, 29.1), and thyroid (CR, 43.7; ASR, 31.1), accounting for 65.9% of all new cancers in 2016.

In women, the five leading primary sites are expected to be the thyroid (CR, 133.5; ASR, 96.2), breast (CR, 79.3; ASR, 52.2), colon and rectum (CR, 56.8; ASR, 30.5), stomach (CR, 42.8; ASR, 23.5), and lung (CR, 31.8; ASR, 16.0), accounting for 71.4% of all new cancers ([Fig. 1](#f1-crt-2016-092){ref-type="fig"}). Thyroid cancer alone is projected to account for approximately 27.7% (34,255 cases) of incident cases in women in 2016.

The five most common cancer sites expected in 2016 by sex and age group are shown in [Table 3](#t3-crt-2016-092){ref-type="table"}. Leukemia and thyroid cancer are expected to be the most common types of cancer in both genders for the 0-14 and 15-34 age groups. Stomach cancer is predicted to be the most prevalent in men aged 35-64 years, while lung cancer is expected to be more frequent in men aged 65 and over. Thyroid cancer is predicted to be the most common cancer in women 35-64 years of age, whereas colorectal cancer is expected to be the most prevalent in women aged 65 and over. These projections indicate that the incidences of stomach, lung, liver, colorectal, and prostate cancers will increase gradually with age for men. In women, the age-specific incidence rates of stomach, colorectal, liver, lung, and cervical cancers denote a rising trend in these cancers with age; however, the incidence of breast and thyroid cancer in women is expected to level off after the late 40s and early 50s, respectively ([Fig. 2](#f2-crt-2016-092){ref-type="fig"}).

2. Mortality
------------

It is estimated that 75,172 cancer deaths will occur in Korea in 2016 ([Table 1](#t1-crt-2016-092){ref-type="table"}, [Fig. 1](#f1-crt-2016-092){ref-type="fig"}). The projected CRs per 100,000 of all sites combined in 2016 for men and women are projected to be 179.8 and 113.1, respectively, whereas the projected ASRs per 100,000 of all sites combined are expected to be 116.2 and 53.1, respectively ([Table 4](#t4-crt-2016-092){ref-type="table"}). The predicted five leading cancer sites causing mortality in men are predicted to be lung (CR, 49.4; ASR, 31.2), liver (CR, 30.6; ASR, 19.7), colon and rectum (CR, 20.1; ASR, 13.0), stomach (CR, 17.1; ASR, 11.0), and pancreas (CR, 11.2; ASR, 7.2). During the same period, lung cancer (CR, 18.8; ASR, 8.3) is projected to be the leading cancer site in women, causing mortality, followed by the colon and rectum (CR,13.9; ASR, 6.0), liver (CR, 10.9; ASR, 5.0), stomach (CR, 10.3; ASR, 4.5), and pancreas (CR, 10.2; ASR, 4.6).

The predicted age-specific mortality rates of the selected cancers for males and females in 2016 are shown in further detail in [Fig. 3](#f3-crt-2016-092){ref-type="fig"}. When examined by age, Korean men and women aged 60 and over are expected to have the highest mortality rates from lung cancer.

Conclusion
==========

A total of 254,962 new cancer cases and 74,096 cancer deaths are expected to occur in Korea during 2016. The colorectal cancer is predicted to the most common cancer among male for the first time, followed by stomach, lung, liver, and thyroid cancers. Lung, liver, colorectal, stomach, and pancreatic cancers are expected to be the most common causes of cancer deaths among men. In women, the five leading primary sites are expected to be the thyroid, breast, colorectal, stomach, and lung cancers are anticipated to be the most prevalent, while lung, colorectal, liver, stomach, and pancreatic cancers are projected to be the most common causes of cancer-related deaths.

Cancer is currently one of the foremost public health concerns in Korea. Although cancer rates are anticipated to decrease somewhat, but cancer burden will continue to increase with the aging of its population. The current projections of cancer incidence and mortality for 2016 represent an important resource for planning and evaluating cancer-control programs. As the estimates in this study are model-based, these results should be interpreted with caution.Cancer is currently one of the foremost public health concerns in Korea. Although cancer rates are anticipated to decrease somewhat, but cancer burden will continue to increase with the aging of its population. The current projections of cancer incidence and mortality for 2016 represent an important resource for planning and evaluating cancer-control programs. As the estimates in this study are modelbased, these results should be interpreted with caution.
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###### 

Estimated new cancer cases and deaths by sex during 2016 in Korea

  Site                                                         Estimated new cases   Estimated deaths                               
  ------------------------------------------------------------ --------------------- ------------------ --------- -------- -------- --------
  All sites                                                    254,962               131,224            123,738   75,172   46,155   29,017
  Lip, oral cavity, and pharynx                                3,236                 2,363              873       1,059    775      284
  Esophagus                                                    2,335                 2,137              198       1,199    1,125    74
  Stomach                                                      34,331                23,355             10,976    7,054    4,402    2,652
  Colon and rectum                                             37,968                23,406             14,562    8,715    5,147    3,568
  Liver                                                        16,014                11,558             4,456     10,639   7,846    2,793
  Gallbladder^[a)](#tfn2-crt-2016-092){ref-type="table-fn"}^   5,831                 3,029              2,802     3,994    1,927    2,067
  Pancreas                                                     6,431                 3,428              3,003     5,487    2,863    2,624
  Larynx                                                       1,033                 1,000              33        342      339      3
  Lung                                                         25,052                16,903             8,149     17,505   12,676   4,829
  Breast                                                       20,429                73                 20,356    2,452    19       2,433
  Cervix uteri                                                 3,013                 \-                 3,013     755      \-       755
  Corpus uteri                                                 2,565                 \-                 2,565     296      \-       296
  Ovary                                                        2,450                 \-                 2,450     1,097    \-       1,097
  Prostate                                                     11,062                11,062             \-        1,862    1,862    \-
  Testis                                                       269                   269                \-        19       19       \-
  Kidney                                                       4,961                 3,456              1,505     1,046    726      320
  Bladder                                                      3,824                 3,051              773       1,412    1,076    336
  Brain and CNS                                                1,929                 1,026              903       1,160    620      540
  Thyroid                                                      45,474                11,219             34,255    360      103      257
  Hodgkin lymphoma                                             308                   199                109       69       44       25
  Non-Hodgkin lymphoma                                         5,538                 3,027              2,511     1,661    955      706
  Multiple myeloma                                             1,555                 833                722       921      510      411
  Leukemia                                                     3,223                 1,822              1,401     1,760    1,015    745
  Other and ill defined                                        16,131                8,008              8,123     4,308    2,106    2,202

CNS, central nervous system.

Includes the gallbladder and other/unspecified parts of the biliary tract.

###### 

Estimated crude and age-standardized cancer incidences by sex during 2016 in Korea

  Site                                                         Crude incidence rate per 100,000   Age-standardized incidence rate per 100,000^[a)](#tfn4-crt-2016-092){ref-type="table-fn"}^                           
  ------------------------------------------------------------ ---------------------------------- -------------------------------------------------------------------------------------------- ------- ------- ------- -------
  All sites                                                    496.7                              511.2                                                                                        482.3   311.0   340.0   298.8
  Lip, oral cavity, and pharynx                                6.3                                9.2                                                                                          3.4     4.0     6.1     2.1
  Esophagus                                                    4.6                                8.3                                                                                          0.8     2.6     5.4     0.4
  Stomach                                                      66.9                               91.0                                                                                         42.8    39.8    59.0    23.5
  Colon and rectum                                             74.0                               91.2                                                                                         56.8    43.9    59.6    30.5
  Liver                                                        31.2                               45.0                                                                                         17.4    18.5    29.1    9.1
  Gallbladder^[b)](#tfn5-crt-2016-092){ref-type="table-fn"}^   11.4                               11.8                                                                                         10.9    6.2     7.6     5.0
  Pancreas                                                     12.5                               13.4                                                                                         11.7    7.0     8.6     5.7
  Larynx                                                       2.0                                3.9                                                                                          0.1     1.2     2.5     0.1
  Lung                                                         48.8                               65.9                                                                                         31.8    27.3    42.3    16.0
  Breast                                                       39.8                               0.3                                                                                          79.3    26.2    0.2     52.2
  Cervix uteri                                                 5.9                                \-                                                                                           11.7    3.9     \-      7.5
  Corpus uteri                                                 5.0                                \-                                                                                           10.0    3.2     \-      6.4
  Ovary                                                        4.8                                \-                                                                                           9.6     3.2     \-      6.4
  Prostate                                                     21.6                               43.1                                                                                         \-      12.4    28.0    \-
  Testis                                                       0.5                                1.1                                                                                          \-      0.5     1.0     \-
  Kidney                                                       9.7                                13.5                                                                                         5.9     6.1     8.9     3.5
  Bladder                                                      7.5                                11.9                                                                                         3.0     4.1     7.7     1.3
  Brain and CNS                                                3.8                                4.0                                                                                          3.5     3.0     3.4     2.7
  Thyroid                                                      88.6                               43.7                                                                                         133.5   63.3    31.1    96.2
  Hodgkin lymphoma                                             0.6                                0.8                                                                                          0.4     0.5     0.7     0.4
  Non-Hodgkin lymphoma                                         10.8                               11.8                                                                                         9.8     7.4     8.6     6.3
  Multiple myeloma                                             3.0                                3.3                                                                                          2.8     1.8     2.1     1.5
  Leukemia                                                     6.3                                7.1                                                                                          5.5     5.3     6.2     4.4
  Other and ill defined                                        31.4                               31.2                                                                                         31.7    19.6    22.0    17.6

CNS, central nervous system.

Age adjusted to the world standard population,

Includes the gallbladder and other/unspecified parts of the biliary tract.

###### 

Estimated cancer incidence by age group and sex during 2016 in Korea

  Rank         Age group (yr)                                                                  
  ------------ ---------------------------- ------------------------ ------------------------- --------------------------
  **Male**                                                                                     
  1            Leukemia (5.0)               Thyroid (23.5)           Stomach (98.7)            Lung (434.3)
  2            Non-Hodgkin lymphoma (2.6)   Colon and rectum (3.6)   Colon and rectum (96.6)   Colon and rectum (425.6)
  3            Brain and CNS (2.4)          Leukemia (3.4)           Thyroid (70.1)            Stomach (418.8)
  4            Liver (0.5)                  Non-Hodgkin lymphoma     (3.3) Liver (54.4)        Prostate (303.5)
  5            Thyroid (0.4)                Stomach (2.0)            Lung (41.9)               Liver (182.2)
  **Female**                                                                                   
  1            Leukemia (4.0)               Thyroid (79.7)           Thyroid (216.8)           Colon and rectum (214.6)
  2            Brain and CNS (2.0)          Breast (12.0)            Breast (141.8)            Stomach (152.0)
  3            Non-Hodgkin lymphoma (1.5)   Cervix uteri (5.5)       Colon and rectum (53.2)   Lung (137.0)
  4            Ovary (0.8)                  Stomach (3.4)            Stomach (42.5)            Thyroid (93.3)
  5            Thyroid (0.7)                Ovary (3.1)              Lung (24.8)               Breast (77.7)

CNS, central nervous system.

###### 

Estimated crude and age-standardized cancer mortality rates by sex during 2016 in Korea

  Site                                                         Crude mortality rate per 100,000   Age-standardized mortality rate per 100,000^[a)](#tfn8-crt-2016-092){ref-type="table-fn"}^                          
  ------------------------------------------------------------ ---------------------------------- -------------------------------------------------------------------------------------------- ------- ------ ------- ------
  All sites                                                    146.5                              179.8                                                                                        113.1   79.3   116.2   53.1
  Lip, oral cavity, and pharynx                                2.1                                3.0                                                                                          1.1     1.2    1.9     0.5
  Esophagus                                                    2.3                                4.4                                                                                          0.3     1.3    2.8     0.1
  Stomach                                                      13.7                               17.1                                                                                         10.3    7.2    11.0    4.5
  Colon and rectum                                             17.0                               20.1                                                                                         13.9    8.9    13.0    6.0
  Liver                                                        20.7                               30.6                                                                                         10.9    11.8   19.7    5.0
  Gallbladder^[b)](#tfn9-crt-2016-092){ref-type="table-fn"}^   7.8                                7.5                                                                                          8.1     3.9    4.8     3.3
  Pancreas                                                     10.7                               11.2                                                                                         10.2    5.8    7.2     4.6
  Larynx                                                       0.7                                1.3                                                                                          0.0     0.3    0.8     0.0
  Lung                                                         34.1                               49.4                                                                                         18.8    17.8   31.2    8.3
  Breast                                                       4.8                                0.1                                                                                          9.5     2.9    0.0     5.7
  Cervix uteri                                                 1.5                                \-                                                                                           2.9     0.8    \-      1.6
  Corpus uteri                                                 0.6                                \-                                                                                           1.2     0.3    \-      0.7
  Ovary                                                        2.1                                \-                                                                                           4.3     1.3    \-      2.4
  Prostate                                                     3.6                                7.3                                                                                          \-      1.7    4.8     \-
  Testis                                                       0.0                                0.1                                                                                          \-      0.0    0.1     \-
  Kidney                                                       2.0                                2.8                                                                                          1.2     1.1    1.8     0.6
  Bladder                                                      2.8                                4.2                                                                                          1.3     1.3    2.8     0.5
  Brain and CNS                                                2.3                                2.4                                                                                          2.1     1.6    1.8     1.3
  Thyroid                                                      0.7                                0.4                                                                                          1.0     0.3    0.3     0.4
  Hodgkin lymphoma                                             0.1                                0.2                                                                                          0.1     0.1    0.1     0.1
  Non-Hodgkin lymphoma                                         3.2                                3.7                                                                                          2.8     1.8    2.4     1.3
  Multiple myeloma                                             1.8                                2.0                                                                                          1.6     1.0    1.3     0.8
  Leukemia                                                     3.4                                4.0                                                                                          2.9     2.2    2.8     1.7
  Other and ill defined                                        8.4                                8.2                                                                                          8.6     4.7    5.6     4.0

CNS, central nervous system.

Age adjusted to the world standard population,

Includes the gallbladder and other/unspecified parts of the biliary tract.
